Big Biotech Outpaces Big Pharma, Burrill & Company Says
4/17/2013 11:00:28 AM
More...
|
Burrill & Company Touts New Life Sciences Fund Worth $505 Million
8/3/2012 7:45:00 AM
More...
|
Pharma Partnering Dollars Continue to Decline for Biotech, Burrill & Company Reports
8/1/2012 10:24:22 AM
More...
|
Burrill & Company Launches Investment Research With Addition of Respected Team of Analysts
8/1/2012 8:57:49 AM
More...
|
Burrill & Company Release: Life Sciences M&A Values Soar in 2011
5/14/2012 8:29:40 AM
More...
|
Life Sciences M&A Activity Heats Up in April, Says Burrill & Company
5/1/2012 8:53:35 AM
More...
|
Burrill & Company Release: Improving Market Drives Life Sciences Financings in February
3/1/2012 8:33:08 AM
More...
|
Burrill & Company Expands Into Taiwan
2/24/2012 9:02:20 AM
More...
|
Burrill & Company Advises Aldagen, Inc. (ALDH) in Sale of Its Next Generation Cell Therapy to Cytomedix Inc. (CMXI)
2/21/2012 9:03:47 AM
More...
|
Burrill & Company Release: Biotech Dealmaking Gets Off to a Strong Start in 2012
2/1/2012 8:48:22 AM
More...
|
|